SINGAPORE: Temasek Holdings has posted a record performance on the back of a strong showing in the Singapore and China markets in its last financial year. Its net portfolio value climbed to an all-time high of $266 billion as of March 31, surging $43 billion over the previous 12 months, it said here the other day.
The investment company’s one- year total shareholder return – a measure of how hard its investment funds are working – was 19.2 per cent, making this one of the strongest years on record.
This measure includes dividends paid to its shareholder, the Finance Ministry, but not capital injections from the ministry. Temasek’s shareholder did not make any net capital injections in the last financial year.
Chairman Lim Boon Heng said the April 2014 to March 2015 period was the most active year for the investment company since the global financial crisis. It made $30 billion worth of new investments, almost half in Asia, with the rest in North America and Europe.
Mr Ravi Lambah, senior managing director of investments, said Temasek’s top sectors for new investments over the year were consumer products, financial services, life sciences and agriculture.
It made $30 billion worth of new investments, almost half in Asia, with the rest in North America and Europe. The company’s top sectors for new investments over the year were consumer products, financial services, life sciences and agriculture.
These included a US$5.7 billion (S$7.7 billion) investment in consumer giant A.S. Watson, a US$800 million stake in US-based biopharmaceutical company Gilead Sciences, as well as investments in transportation network company Didi Kuaidi in China and South-east Asia-based e-commerce platform Lazada.
